Trial · NCT04327843
Results by group21
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 21
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Tablets Routine Questionnaire (TRQ) | CAE + LAI Treatment | TRQ Week adherence | -57 | Standard Deviation 60.8 | percentage of change in adherence |
| Tablets Routine Questionnaire (TRQ) | CAE + LAI Treatment | TRQ Month adherence | -23 | Standard Deviation 0 | percentage of change in adherence |
| Long-Acting Injectable Adherence (LAI Adherence): Count of Participants Who Received All LAI Injections: | CAE + LAI Treatment | 18 | Participants | ||
| Drug Attitude Inventory (DAI) | CAE + LAI Treatment | Baseline | 7.89 | Standard Deviation 2.72 | score on a scale |
| Drug Attitude Inventory (DAI) | CAE + LAI Treatment | 25 Weeks | 9.83 | Standard Deviation 0.52 | score on a scale |
| Brief Psychiatric Rating Scale (BPRS) | CAE + LAI Treatment | Baseline | 27.00 | Standard Deviation 10.26 | score on a scale |
| Brief Psychiatric Rating Scale (BPRS) | CAE + LAI Treatment | 25-Weeks | 25.06 | Standard Deviation 8.53 | score on a scale |
| Clinical Global Impressions (CGI) | CAE + LAI Treatment | Baseline | 2.88 | Standard Deviation 1.32 | units on a scale |
| Clinical Global Impressions (CGI) | CAE + LAI Treatment | 25 Weeks | 2.24 | Standard Deviation 1.09 | units on a scale |
| Social and Occupational Functioning Scale (SOFAS) | CAE + LAI Treatment | Baseline | 62.17 | Standard Deviation 18.28 | score on a scale |
| Social and Occupational Functioning Scale (SOFAS) | CAE + LAI Treatment | 25 Weeks | 68.39 | Standard Deviation 15.28 | score on a scale |
| Body Mass Index | CAE + LAI Treatment | Baseline | 22.79 | Standard Deviation 5.02 | kg/m^2 |
| Body Mass Index | CAE + LAI Treatment | 25 Weeks | 22.92 | Standard Deviation 5.58 | kg/m^2 |
| ESRS-A Parkinsonism | CAE + LAI Treatment | Baseline | 0.06 | Standard Deviation 0.24 | score on a scale |
| ESRS-A Parkinsonism | CAE + LAI Treatment | 25 Weeks | 0.06 | Standard Deviation 0.24 | score on a scale |
| ESRS-A Dystonia | CAE + LAI Treatment | Baseline | 0.00 | Standard Deviation 0.00 | score on a scale |
| ESRS-A Dystonia | CAE + LAI Treatment | Week 25 | 0.00 | Standard Deviation 0.00 | score on a scale |
| ESRS-A Dyskinesia | CAE + LAI Treatment | Baseline | 0.17 | Standard Deviation 0.51 | score on a scale |
| ESRS-A Dyskinesia | CAE + LAI Treatment | Week 25 | 0.11 | Standard Deviation 0.47 | score on a scale |
| ESRS-A Akathisia | CAE + LAI Treatment | Baseline | 0.28 | Standard Deviation 0.75 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04327843/results